These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15897313)

  • 21. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
    Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
    Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Radosevich M; Jager M; Ono SJ
    Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter polymorphisms in the IRF3 gene confer protection against systemic lupus erythematosus.
    Akahoshi M; Nakashima H; Sadanaga A; Miyake K; Obara K; Tamari M; Hirota T; Matsuda A; Shirakawa T
    Lupus; 2008 Jun; 17(6):568-74. PubMed ID: 18539711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms/mutations of TCR-zeta-chain promoter and 3' untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3' untranslated region in patients with systemic lupus erythematosus.
    Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Kammer GM; Tsokos GC
    J Autoimmun; 2001 Mar; 16(2):133-42. PubMed ID: 11247639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus.
    Miyagawa H; Yamai M; Sakaguchi D; Kiyohara C; Tsukamoto H; Kimoto Y; Nakamura T; Lee JH; Tsai CY; Chiang BL; Shimoda T; Harada M; Tahira T; Hayashi K; Horiuchi T
    Rheumatology (Oxford); 2008 Feb; 47(2):158-64. PubMed ID: 18174230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p21 gene polymorphisms in systemic lupus erythematosus.
    Kong EK; Chong WP; Wong WH; Lau CS; Chan TM; Ng PK; Song YQ; Mak W; Lau YL
    Rheumatology (Oxford); 2007 Feb; 46(2):220-6. PubMed ID: 16837471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis.
    Kawasaki A; Tsuchiya N; Fukazawa T; Hashimoto H; Tokunaga K
    Genes Immun; 2002 Nov; 3(7):424-9. PubMed ID: 12424625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.
    LeibundGut-Landmann S; Waldburger JM; Krawczyk M; Otten LA; Suter T; Fontana A; Acha-Orbea H; Reith W
    Eur J Immunol; 2004 Jun; 34(6):1513-25. PubMed ID: 15162420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with nephritis and arthritis in systemic lupus erythematosus.
    Hur JW; Sung YK; Shin HD; Park BL; Cheong HS; Bae SC
    Rheumatology (Oxford); 2006 Jun; 45(6):711-7. PubMed ID: 16461442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus.
    Guarnizo-Zuccardi P; Lopez Y; Giraldo M; Garcia N; Rodriguez L; Ramirez L; Uribe O; Garcia L; Vasquez G
    Tissue Antigens; 2007 Nov; 70(5):376-82. PubMed ID: 17711410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the FcgammaRIIA promoter and 5'UTR sequences in patients with systemic lupus erythematosus.
    Pricop L; Li L; Salmon JE; Jacob CO
    Genes Immun; 2002 Oct; 3 Suppl 1():S47-50. PubMed ID: 12215902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus.
    Matsushita M; Tsuchiya N; Oka T; Yamane A; Tokunaga K
    Genes Immun; 2000 Oct; 1(7):428-34. PubMed ID: 11196673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups.
    Akkad DA; Jagiello P; Szyld P; Goedde R; Wieczorek S; Gross WL; Epplen JT
    Int J Immunogenet; 2006 Feb; 33(1):59-61. PubMed ID: 16426246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
    Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
    Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential nerve injury-induced expression of MHC class II in the mouse correlates to genetic variability in the type I promoter of C2ta.
    Harnesk K; Swanberg M; Diez M; Olsson T; Piehl F; Lidman O
    J Neuroimmunol; 2009 Jul; 212(1-2):44-52. PubMed ID: 19481818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic silencing of MHC2TA transcription in cancer.
    Holling TM; van Eggermond MC; Jager MJ; van den Elsen PJ
    Biochem Pharmacol; 2006 Nov; 72(11):1570-6. PubMed ID: 16879803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells.
    LeibundGut-Landmann S; Waldburger JM; Reis e Sousa C; Acha-Orbea H; Reith W
    Nat Immunol; 2004 Sep; 5(9):899-908. PubMed ID: 15322541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variants of chemokine receptor CCR7 in patients with systemic lupus erythematosus, Sjogren's syndrome and systemic sclerosis.
    Kahlmann D; Davalos-Misslitz AC; Ohl L; Stanke F; Witte T; Förster R
    BMC Genet; 2007 Jun; 8():33. PubMed ID: 17587445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An analysis on the relationship between susceptibility to cirrhosis and polymorphisms at C-1350T and G-944C sites of CIITA gene promoter IV in chronic HBV carriers].
    Hong XJ; Zhang XQ; Bai XJ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):38-42. PubMed ID: 18226342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency.
    Dziembowska M; Fondaneche MC; Vedrenne J; Barbieri G; Wiszniewski W; Picard C; Cant AJ; Steimle V; Charron D; Alca-Loridan C; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2002 Feb; 53(10-11):821-9. PubMed ID: 11862382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.